Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Stirban: Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?. (0.12 sec) 

Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?

- Free from Publisher
AO Stirban, D Tschoepe - Diabetes Care, 2008 - Am Diabetes Assoc
The reality of primary and secondary prevention of cardiovascular complications
in people with diabetes is alarming, even in developed countries with a
well-structured medical system. Even though therapeutic targets have been ...
Cited by 1 - Related articles - BL Direct - All 5 versions

关于复方中成药的临床应用与研究


陈可冀 - 中国中西医结合杂志, 2004 - cqvip.com
错误号:0. 您所请求的页面暂时无法打开可能由于当前访问的
人数过多系统繁忙,或网速过慢。 请稍后再访问 ...
Cited by 4 - Related articles - All 4 versions

" Polypill" Could Slash Diabetes Risks


BM Kuehn - JAMA, 2006 - Am Med Assoc
The proposal for a "polypill" treatment for patients with diabetes was one of a
host of presentations at the conference addressing challenges in diabetes care.
Physicians and scientists at the meeting emphasized the need to overcome " ...
Cited by 9 - Related articles - All 4 versions

[CITATION] de LC, Peeters A, Steyerberg EW, Mackenbach JP: The Polymeal: a more natural, safer, and …


OH Franco, L Bonneux - BMJ, 2004
Cited by 3 - Related articles

“Polypill” to fight cardiovascular disease: Authors' reply

- nih.gov [PDF] 
N Wald, M Law, J Morris, A Rudnicka, R … - BMJ: British Medical Journal, 2003 - pubmedcentral.nih.gov
Patients before populations Editor—Wald and Law's provocative paper and the
accompanying editorial on the “Polypill” was disappointing in focusing only
on the advantage to the population and ignoring the individual's views of ...
Cited by 3 - Related articles - All 3 versions

“Polypill” to fight cardiovascular disease: Now who's playing God?

- nih.gov [PDF] 
S Taylor, A Konings - BMJ: British Medical Journal, 2003 - pubmedcentral.nih.gov
Patients before populations Editor—Wald and Law's provocative paper and the
accompanying editorial on the “Polypill” was disappointing in focusing only
on the advantage to the population and ignoring the individual's views of ...
Cited by 2 - Related articles - All 5 versions

多效药片 (polypill) 的临床应用与中成药的研发


陈可冀, 蒋跃绒 - 中国中西医结合杂志, 2009 - cqvip.com
首页; 期刊大全; 知识社区; 学者空间; 学术机构; 专题导读; 充值中心.
客服中心. 维普资讯 中文期刊·专业文章. 维普专业检索. ...
Related articles

Gap between guidelines and practice: attainment of treatment targets in patients with …


G Assmann, H Benecke, A Neiss, P Cullen, H … - European Journal of Cardiovascular Prevention & …, 2006 - journals.lww.com
Background The aim of this study was to determine the achievement of National
Cholesterol Education Program Adult Treatment Panel III goals in patients with
primary hypercholesterolemia starting statin therapy in clinical practice. ...
Cited by 11 - Related articles - BL Direct - All 11 versions

Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in …

- detect-studie.de [PDF] 
S Böhler, H Scharnagl, F Freisinger, T … - Atherosclerosis, 2007 - Elsevier
DETECT is a cross-sectional study of 55,518 unselected consecutive patients in
3188 representative primary care offices in Germany. In a random subset of 7519
patients, an extensive standardized laboratory program was undertaken. The ...
Cited by 12 - Related articles - All 8 versions

Benefits, challenges, and registerability of the polypill

- oxfordjournals.org
P Sleight, H Pouleur, F Zannad - European heart journal, 2006 - Eur Soc Cardiology
Guidelines for the management of cardiovascular disease (CVD) stress the
importance of treating global risk, rather than individual risk, factors.
Patients at high cardiovascular (CV) risk, for example, benefit from a ...
Cited by 34 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google